Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.10.3.1 (tyrosinase)
 9,065 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The present study deals with the microbiological transformation of L-tyrosine to 3,4-dihydroxyphenyl L-alanine by a mutant strain of Aspergillus oryzae UV-7. Sixteen different mutant strains of Aspergillus oryzae (GCB-6) were isolated through UV-irradiation. These mutant strains were screened for the production of mold mycelia by submerged fermentation in 250-ml Erlenmeyer flasks. Of all the mutant strains examined, UV-7 gave maximum production of L-dopa (1.28 mg/ml). The reaction was carried out using mold mycelium as a source of enzyme tyrosinase in shake flasks. The maximum production of L-dopa was obtained when glucose (25 mg/ml) was used as the carbon source and NH(4)Cl (3 mg/ml) was used as the nitrogen source. The optimum pH for mycelium development was 5.0; L-dopa production was maximum at pH 3.5 of the reaction mixture. The reaction by mold mycelium (75 mg/ml) was carried out under acidic conditions. Optimum temp, time, and L-tyrosine concentration were 55 degrees C, 60 min, and 3.0 mg/ml, respectively.
 ...
PMID:Microbiological transformation of L-tyrosine to 3,4-dihydroxyphenyl L-alanine (L-dopa) by a mutant strain of Aspergillus oryzae UV-7. 1207 Jun 84

The present investigation deals with the biosynthesis of L-DOPA by parental (GCB-6) and mutant (UV-7) strains of Aspergillus oryzae. There was a marked difference between the mycelial morphology and pellet type of parental and UV-irradiated mutant culture. The mutant strain of A. oryzae UV-6 exhibited pellet-like mycelial morphology and improved tyrosinase activity. Mould mycelium was used for biochemical conversion of L-tyrosine to L-DOPA because tyrosinase is an intracellular enzyme. The mutant was found to yield 3.72 fold higher production of L-DOPA than the parental strain. The mutant strain is stable and D-glc-resistant. The comparison of kinetic parameters was also done which showed the greater ability of the mutant to yield L-DOPA (i.e., Yp/x 40.00+/-0.01 d mg/mg with parent and 182.86+/-0.02a mg/mg in case of mutant). When cultures grown for various incubation periods, were monitored for Qp, Qs and q(p), there was significant enhancement (p < 0.0025-0.005) in these variables by the mutant strain of A. oryzae UV-7 over GCB-6 on all the rates. L-DOPA (3,4-dihydroxy phenyl L-alanine) is a drug of choice in the treatment of Parkinson's disease and myocardium following neurogenic injury.
 ...
PMID:Biosynthesis of L-DOPA by Aspergillus oryzae. 1214 38